Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3397)
All Articles published online
|
Nov 7, 2006 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He XP, Li ZS, Zhu RM, Tu ZX, Gao J, Pan X, Gong YF, Jin J, Man XH, Wu HY, Xu AF. Effects of recombinant human canstatin protein in the treatment of pancreatic cancer. World J Gastroenterol 2006; 12(41): 6652-6657 [PMID: PMC4125671 DOI: 10.3748/wjg.v12.i41.6652] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6652.htm |
| Number | Citing Articles |
| 1 |
Xiao-Ping He, Chang-Qing Su, Xing-Hua Wang, Xue Pan, Zhen-Xing Tu, Yang-Fang Gong, Jun Gao, Zhuan Liao, Jing Jin, Hong-Yu Wu, Xiao-Hua Man, Zhao-Shen Li. E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer. Cancer Letters 2009; 285(1): 89 doi: 10.1016/j.canlet.2009.05.006
|
| 2 |
Reyhane Chamani, Mohammad Hossein Taleqani, Aylar Imanpour, Mehri Khatami. New insights into short peptides derived from the collagen NC1 α1, α2, and α3 (IV) domains: An experimental and MD simulations study. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2022; 1870(4): 140769 doi: 10.1016/j.bbapap.2022.140769
|
| 3 |
Akira Sugiyama, Rumi Ito, Muneyoshi Okada, Hideyuki Yamawaki. Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-69736-y
|
| 4 |
Malin Sund, Pia Nyberg, Hans Petter Eikesdal. Endogenous Matrix-Derived Inhibitors of Angiogenesis. Pharmaceuticals 2010; 3(10): 3021 doi: 10.3390/ph3103021
|
| 5 |
Jean Claude Monboisse, Karine Sénéchal, Jessica Thevenard, Laurent Ramont, Sylvie Brassart-Pasco, François-Xavier Maquart. Matrikines : une nouvelle stratégie thérapeutique anti-cancéreuse. Biologie Aujourd'hui 2012; 206(2): 111 doi: 10.1051/jbio/2012017
|
| 6 |
Sheng-Chao Wang, Tzong-Huei Lee, Chun-Hua Hsu, Yu-Jia Chang, Man-Shan Chang, Yi-Ching Wang, Yuan-Soon Ho, Wu-Che Wen, Ruo-Kai Lin. Antroquinonol D, Isolated from Antrodia camphorata, with DNA Demethylation and Anticancer Potential. Journal of Agricultural and Food Chemistry 2014; 62(24): 5625 doi: 10.1021/jf4056924
|
| 7 |
Akira Sugiyama, Maina Kaisho, Muneyoshi Okada, Kosuke Otani, Hideyuki Yamawaki. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling. International Journal of Molecular Sciences 2020; 21(18): 6797 doi: 10.3390/ijms21186797
|
| 8 |
Dilara Aylar, Ayse Karatug Kacar. Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01142-5
|
| 9 |
Akira Sugiyama, Muneyoshi Okada, Kosuke Otani, Hideyuki Yamawaki. Development of basic research toward clinical application of cleaved fragment of type IV collagen. Folia Pharmacologica Japonica 2021; 156(5): 282 doi: 10.1254/fpj.21016
|
| 10 |
Ashley M. Fuller, Tzipora S. Karin Eisinger-Mathason. Context Matters: Response Heterogeneity to Collagen-Targeting Approaches in Desmoplastic Cancers. Cancers 2022; 14(13): 3132 doi: 10.3390/cancers14133132
|
| 11 |
Fan Zhang, Jingjing Duan, Hailin Song, Li Yang, Ming Zhou, Xuewen Wang. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma. Drug Development Research 2021; 82(3): 430 doi: 10.1002/ddr.21766
|
| 12 |
Muneyoshi Okada, Hideyuki Yamawaki. A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain. Journal of Pharmacological Sciences 2019; 139(2): 59 doi: 10.1016/j.jphs.2018.12.001
|
| 13 |
Jeon Hwang‐Bo, Ki Hyun Yoo, Jong‐Hwa Park, Han‐Sin Jeong, In Sik Chung. Recombinant canstatin inhibits angiopoietin‐1‐induced angiogenesis and lymphangiogenesis. International Journal of Cancer 2012; 131(2): 298 doi: 10.1002/ijc.26353
|
| 14 |
Lingyu Zhu, Long Ao, Zitao Guo, Yuliang Yang, Zilong Wang, Zhenghua Gu, Yu Xin, Leyuan Zhou, Liang Zhang. Recombinant canstatin inhibits the progression of hepatocellular carcinoma by repressing the HIF-1α/VEGF signaling pathway. Biomedicine & Pharmacotherapy 2024; 179: 117423 doi: 10.1016/j.biopha.2024.117423
|